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The location of the translational termination codon for the transmembrane protein (TMP) varies in three
infectious molecular clones of simian immunodeficiency virus from macaques (SIVmac). The SIV.aC251 and
SIVmaC142 infectious clones have premature stop signals that differ in location by one codon; transfection of
these DNAs into human HUT-78 cells yielded virus with a truncated TMP (28 to 30 kilodaltons [kDa]). The
SIVmaC239 infectious clone does not have a premature stop codon in its TMP-coding region. Transfection of
HUT-78 cells with this clone initially yielded virus with a full-length TMP (41 kDa). At 20 to 30 days
posttransfection, SIVmac239 virus with a 41-kDa TMP gradually disappeared coincident with the emergence of
a virus with a 28-kDa TMP. Virus production dramatically increased in parallel with the emergence of a virus
with a 28-kDa TMP. Sequence analysis of viral DNAs from these cultures showed that premature stop codons
arising by point mutation were responsible for the change in size of the TMP with time. A similar selective
pressure for truncated forms of TMP was observed when the SIVmaC239 clone was transfected into human
peripheral blood lymphocytes (PBL). In contrast, no such selective pressure was observed in macaque PBL.
When the SIVmac239 clone was transfected into macaque PBL and the resultant virus was serially passaged in
macaque PBL, the virus replicated very well and maintained a 41-kDa TMP for 80 days in culture. Macaque
monkeys were infected with SIVmac239 having a 28-kDa TMP; virus subsequently recovered from T4-enriched
lymphocytes of peripheral blood showed only the 41-kDa form of TMP. These results indicate that the natural
form ofTMP in SIVmaC is the full-length 41-kDa TMP, just as in human immunodeficiency virus type 1. Viruses
with truncated forms of TMP appear to result from mutation and selection during propagation in unnatural
human cells.
Two related but distinct human lentiviruses, human im-
munodeficiency virus types 1 and 2 (HIV-1 and HIV-2), have
been identified (1, 5, 27). The simian immunodeficiency
viruses (SIVs) are a diverse group of nonhuman primate
lentiviruses that are the closest known relatives of the HIVs.
To date, SIV has been isolated from macaques (3, 6, 8, 24),
African green monkeys (9, 26), sooty mangabey monkeys
(12, 22, 24), and mandrills (31). The SIVs share extensive
similarity with their human counterparts in both genetic and
biological properties. Both SIV and HIV are tropic for cells
bearing the CD4 molecule, and both can be cytopathic for
these cells (6, 19, 26). SIV, like HIV and other lentiviruses,
can induce chronic debilitating disease following long-term
persistent infection. The pathologic features of SIV- and
HIV-induced diseases are quite similar (2, 3, 6, 7, 21, 28).
Both exhibit the unique lentivirus virion morphology. Their
genomic organizations, represented by long terminal repeat-
gag-pol-vip-central region-env-nef-long terminal repeat, are
very similar, with extensive gene-for-gene homology along
the genome (4, 11). The extensive similarity of SIV to HIV
and the ability to induce acquired immunodeficiency syn-
drome in common rhesus monkeys (Macaca mulatta) make
SIV ideally suited for study of the pathogenesis of acquired
immunodeficiency syndrome and approaches to vaccination
and therapy.
One feature of SIV that has been found to differ from
HIV-1 is the length of the transmembrane protein (TMP) of
the envelope. A premature stop codon in the envelope
reading frame results in truncated forms of SIV TMP (4, 11,
* Corresponding author.
16). Some isolates of HIV-2 also contain a truncation of the
TMP (14, 15, 33). These findings have led to speculation as to
whether SIV and HIV-1 differ in the utilization of these
sequences, particularly in the sequences downstream of the
premature stop codon. Since the reading frame in env
beyond the stop codon has been conserved, questions arise
as to whether these sequences may be expressed in alternate
fashion, perhaps through RNA splicing.
Here we report that truncated forms of TMP in SIV from
macaques (SIVmac) result from mutation and selection dur-
ing propagation in unnatural human cell lines and that the
natural form of the TMP in SIVmaC is the full-length 41
kilodaltons (kDa), just as in HIV-1.
MATERIALS AND METHODS
SIVmaC infectious clone. Full-length molecular clones
containing integrated proviral DNA from SIVmaC:142,
SIVmac239, and SIVmac251 in bacteriophage lambda EMBL4
were used. All three of these cloned DNAs were infectious
upon transfection into HUT-78 cells (25).
Cell culture and DNA transfection. The continuously grow-
ing CD4+ human T-cell lines HUT-78 (13) and MT-4 (23)
were maintained in RPMI 1640 medium with 10% fetal
bovine serum. Peripheral blood lymphocytes (PBL) of
healthy macaques and humans were separated by Ficoll-
Hypaque, stimulated with 10 ,ug of phytohemagglutinin per
ml for 48 h at 37°C, and maintained in RPMI 1640 medium
with 20% fetal bovine serum containing 10% human inter-
leukin 2.
Infectious cloned DNAs were transfected into HUT-78
cells and phytohemagglutinin-stimulated macaque and hu-
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man PBL with a DEAE-dextran procedure (25). At 7 to 14
days posttransfection or postinfection of PBL, culture su-
pernatants were used to infect fresh phytohemagglutinin-
stimulated PBL. This procedure was repeated for serial
passage.
Analysis of virus replication and viral products. Virus
replication was analyzed by measurement of reverse tran-
scriptase activity in the culture supernatant (6). For analysis
of viral proteins by immunoblotting, virus particles were
concentrated (1,OOOx) from culture supernatants by being
pelleted in an SW27 rotor (Beckman Instruments, Inc.)
through a 20% sucrose cushion at 25,000 rpm for 2 h. The
crude viral proteins were electrophoresed through sodium
dodecyl sulfate-12% polyacrylamide gels and transferred to
hydrophobic Durapore membranes (Millipore Corp.) by
electroblotting. After the blocking of nonspecific reactions,
the membranes were treated with 1:100 diluted SIVmac-
positive macaque sera for 1 h at 37°C. The membranes were
treated with biotinylated anti-human immunoglobulin (Am-
ersham Corp.) and then with a biotinylated peroxidase-
streptavidin complex (Amersham). Peroxidase activities
were detected by using 0.5 mg of diaminobenzidine per ml
with 0.02% H202 in phosphate-buffered saline.
To assist virus recovery from a macaque persistently
infected with cloned SIVmac239, CD8+ lymphocytes were
depleted by panning (18). This macaque had been inoculated
58 weeks previously with cloned SIVmac239 produced in
HUT-78 cells (25).
Nucleotide sequencing. Hirt supernatant DNA (17) was
prepared from SIVmac239-infected HUT-78 cells. DNA se-
quences between nucleotides 8111 and 8613 (the numbers
correspond to those of SIVmac142 [4]) were specifically
amplified by using the polymerase chain reaction (29). Poly-
merase chain reaction amplifications were performed on an
automated DNA thermal cycler (The Perkin-Elmer Corp.) in
the presence of two synthetic oligonucleotide primers corre-
sponding to 8082 to 8111 and 8613 to 8642. An EcoRI
restriction site was engineered in primer 8082 to 8111 by
replacing adenine with cytosine at nucleotide position 8105.
By using the EcoRI and BglII sites in the synthetic primers,
the 560-base-pair amplified DNA fragment was cloned into
vector pGEM-4Z (Promega Biotec). Nucleotide sequences
in amplified, cloned DNA and in a TMP subclone of the
original infectious SIVmac239 clone were determined by the
primer-directed dideoxy-chain termination method (30). Se-
quenase and synthetic oligonucleotide primers were used to
sequence double-stranded DNA.
RESULTS
The translational stop codon in the SIVmac142 infectious
clone was described previously as part of its entire nucleo-
tide sequence (4). A similar stop codon was found in the
infectious clone of SIVmac251 but not in that of SIVmac239 by
partial sequencing of the TMP region (25). SIVmac142 and
SIVmac251 have stop signals that differ in location by one
codon; no such stop codon was found in this region of
SIVmac239 (Fig. 1A). We confirmed the absence of a prema-
ture stop codon in SIVmac239 by determining the nucleotide
sequence of the entire TMP region (Fig. 1B).
Comparative analysis of the TMP regions of SIVmac239
and SIVmac142 showed an overall nucleotide identity of
95%. However, the homology decreased from 97% before
the stop codon of SIVmac142 to 93% after it; the predicted
amino acid sequence homology decreased from 93% before
the stop codon to 80% after it. The N-terminal region, which
is a putative fusogenic domain, was well conserved. Despite
A 8265 8295 8Y3 8384
SIVmacl42 CAG TAG ACC
SIVmac251 TAG CAG ACT
SIVmac239 CAG CAG ACC
B AV EGP -T- TMPsIvMc239 C AA GAT MA tG MC AT AC GGT AO ACC T~ A MT MA AA GAM TT tm cAAGGAT C TTG GGr
SnrVMcl42 ... ... A^.*... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .....
An
SIvatlaS CIt GA; AGa SCM AGT GC GC G GACG TTMALC MG A C CC CIACT TIA Tit GT GOt
Sr.V142 ... ... ... ... ... ... ... ...... ... ... ... ... ... .... ... . .....GGG.. .... . .
Srvmc239 AM GMT CG CAM CIGCM CM Ct itG GC MtG GMT AM A CMA CM A TIG CGA Cit AC MT GM AAM
SrV -CI42 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G... ....................
Thr
MscC239 AMG MC CTC CM AC MtGG GTC AT GCC ATC GAG AMG TK TA AMG GA CM GCG CMG CIG MT MCT Ta MGA MT GCG
SrVc142 ... ... ... ... ... ... ... T . ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ...
Ser
Lys
sAmcM23 mT AGA CM GTC TGC CM AMACT GTh CCA TGt CCA AAT WA AMT CIA KA CM AM TG AM MT GAM ACr iT CM
SIVMc142 ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... GAT ... ... ... ... ... ... ...
Asp
Glu
sIVAaC239 GAIG ITGG GAG CMA AMG GT GC TC T GA GAAMAT?An ACA WC CC CMA GAM GA GMA CM A C CAA GAG MG
SlVacl42 ... ... ... ..^G ..... ... ... ...^^^ ^G*C.̂-... .. .G ... ... ... ... ... ... ... ... ... ... ... ...
Ala
Ala
SivaacZI AM AlG TAT GAM A CAAA T MT GC ITt GtT GTG T G5C AATT AM CI GCr TCT Itt ATA AMG TAT
Srvmacl42 ..... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...A^.. ... ... ... ... ...
mIr
Vat Val Lys
SIVMac239 ATM CM T MTAGMT MTAT AM MT GT Gt AM Cit MAGA AT GMT ATC TT ATM GTA CM AMG CTA GCT AMG
SIVc142 ... ... ... ... A.. ... ... A.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G-
Ile Ile Arg
Ile
SIV".239 rrA AGG CMG GGt TAMT AM CCA GTG TT TCM TCC CCA CCC TCT MTACTC C1S MC CAT AlT CM C GAC CCG GCA
SIVZ142 --̂A ... ... ... ... ... ... ... ... ... ... ... ... ... T*̂ ^ ... ... ^C. ^^ -*T ^^ *T
Thr
Arg Glu Arg Glu Gly
sAAac239 CT CCA ACC AG GMA GGC MA GAA AG Gi4 GGT GGA GAM GGC GT GGC AAC AGC TCC Ta CCI MGt CAM ATA AM MT
SIVMc142 .. ... ... . ^^^... ..... A^^G^^^^^*-G ^GC- A^ ^^^... ... ... ... ... ... ... ... ... ..*..
Lys Lys Gly Gly Ser
Srvmac239 ATT CA TIC CTG ATC CGC CM CiG AMA CGC CCC AC TaG CTA TMCAG MC MGC AGA ACC M CTA TCG AGA GTA
Ala
SItc123 TAC CMG ATC CTC CAA CCA ATM CTC CAG AGM CTC MT GM ACC CTA CM AMG AM MACGA GTC CTC AGG ACr GM CiT
MArg Leu
Hits Val SIC
sIVmaclI ACC TAC CMA MA TMT GM MGCAGC TMT TTC CAT GGA GM GTC MRGKCC Mt TAGM OGa A AMG MCT GCG
Aln Ala Aln
Asp Thr Arg
SIVac239 GM GCMG WMA MGAGACT MT AG AGlT A TM AMR CC GCA AlC CCC AGG AM AMT AG OCM
SrVM*c42 ... ... ... ... ..A .̂.. ... ... G.... CAA *G ..... ... ...^^^ ^C.. ... ...^^^ ^T ... ... ... ... ...
Glu Ala Gln
SIVW*c239 GMt CT GAG CTC MC CCC AG TM
SrVacl42 ... ... ... ... ... ... ... ...
FIG. 1. (A) Variability in location of the stop codon for TMP.
SVmac142, SlVmac251, and SIVmac239 are infectious molecular
clones from different SIV isolates (25). The premature stop codons
in SIVmaC142 and SIVmaC251 are underlined. (B) Comparison of
nucleotide and predicted amino acid sequences from the TMP
regions of SIVmac239 and SIVmaC142. The cleavage site between the
external glycoprotein (EGP) and transmembrane protein (TMP) is
indicated (32). The identical nucleotide sequences (*) and the
predicted amino acid sequences that differ are shown. A change of
C to T (boxed) results in a stop codon rather than a glutamine at the
indicated position. Nucleotide numbers correspond to those pub-
lished previously for SIVmaCl42 (4).
decreasing homology after the stop codon, the C-terminal 22
amino acids were also well conserved (Fig. 1B).
After transfection of infectious SIVmac251 and SIVmac142
cloned DNAs into HUT-78 cells, the kinetics of virus
replication and the viral products were analyzed. Cloned
SIVmacl42 and SIVmac251 replicated quite well in these
HUT-78 cells and yielded high levels of reverse transcriptase
activity during the course of infection. The size of the TMP
of SIVmac142 was 28 kDa, and that of SIVmac251 was 30
kDa; the size of the TMP was stable in culture over time
(Fig. 2).
Consistent with the DNA sequence, transfection of HUT-
78 cells with SIVmac239 cloned DNA initially yielded a virus
with a full-length 41-kDa TMP (Fig. 3). However, during the
first 20 to 30 days posttransfection, virus replication was
very low compared with that of SIVmaC142 and SIVmac251
(Fig. 3). Upon continued passage of these SIVmac239-trans-
fected cultures, the virus with a 41-kDa TMP gradually
decreased below detectable levels, coincident with the emer-
gence of the virus with a 28-kDa TMP (Fig. 3). Virus
replication increased dramatically concomitant with the
emergence of the virus with a 28-kDa TMP (Fig. 3). Selec-
tion in HUT-78 cells for SIVmac with increased replicative
potential and with truncated forms of TMP was reproduced
in separate experiments (Fig. 3).
Hirt supernatant DNA was prepared from HUT-78 cells
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FIG. 2. Growth kinetics and virion proteins of SIV,.C142 and
SIV,.C251 in HUT-78 cells. Infectious cloned DNAs for SIVmaC142
and SIVmac251 were transfected into HUT-78 cells. Virus produc-
tion was monitored by reverse transcriptase activity in culture
supernatants. Viral proteins were concentrated from culture super-
natants and analyzed by Western blotting (immunoblotting). The
proteins from 19, 47, and 82 days posttransfection are shown. The
TMP for each is indicated. Closed symbols, SIVmacl42; open
symbols, SIVmac251.
EXP. I
Uncloned DAYS AFTER TRANSFECTION
SlVmaC239 14 20 27 34 41 48 55 62 69 76 83 97
p130.-
; 6. --
p55---_-
41KDo- ON s
infected with cloned SIVmac239 after the emergence of
truncated forms of TMP. DNA corresponding to the TMP
region was amplified by a polymerase chain reaction. Am-
plified DNA was cloned, and nucleotide sequences from six
independent clones were analyzed (Fig. 4). Four of the six
clones (To2 to T05) were identical to each other but differed
at one nucleotide (nucleotide 8295) compared with the
parental SIVmac239 clone; a C-to-T change converted a
glutamine codon to a stop codon. The position of this change
corresponded to the position of the premature stop codon in
clone SIVmac251. The analyzed clones otherwise matched
the SIVmaC239 sequence perfectly and differed from the
SIVmac251 and SIVmac142 sequences at several locations. A
fifth clone (TO6) had a stop codon acquired by point mutation
(A--T) six codons downstream (nucleotide 8313) from its
location in T02 to T05. A sixth clone (Tol) had no premature
stop codon in this region (Fig. 4).
A virus stock with predominantly a 41-kDa TMP
(SIVmac239/TM41K obtained 27 days posttransfection) and a
virus stock with predominantly a 28-kDa TMP (SIVmac239/
TM28K obtained 83 days posttransfection) were studied
further. Both were infectious for HUT-78 and MT-4 cells,
both induced syncytia in HUT-78 cells, and both had killing
activity in the MT-4 cell-killing assay. Replication of the
virus with a 28-kDa TMP predominated in both human cell
lines upon infection with SIVmac239/TM28K. When
SIVmac239/TM41K was used to infect cells, selection for the
virus with a truncated 28-kDa TMP occurred in MT-4 and
HUT-78 cells (data not shown). Quite different results were
obtained when SIVmac239/41K and SIVmac239/28K were
used to infect phytohemagglutinin-stimulated macaque PBL
EXP. 2
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FIG. 3. Selection of SIVXnac239 with a truncated TMP in HUT-78 cells. Major viral proteins of uncloned SIVmac239, which was isolated
and maintained in HUT-78 cells, are indicated on the left; this virus has predominantly a truncated form of TMP (28 kDa). The infectious
molecular clone of SIVmaC239 was transfected into HUT-78 cells. The left and right panels show independent experiments (experiments [Exp.]
1 and 2). The correlation between the kinetics of viral replication and the selection of a virus with a truncated TMP is shown. The untruncated
(41-kDa) and truncated (28-kDa) forms of TMP are indicated. RTase, Reverse transcriptase.
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SIV AL239 CCA CC TTC TCT TCC CCA CCC TCT TT TTC CM CAC ACC CCT LTC CM CM GAC CC OCCL CTC CCA ACC ACA CA CCOC ALL CAL ArLCC CC? CCL "A CC CT CC ALC ACC TCC TCC
Pro Va1 Pbs SOw br Pro Pro ar Tyr Pb. Cia CGi Thr Rio I1i CGi CIs Amp Pro Al3. Lou Pro Tbr Ara Clu Cly Lys Glu Arg ALp Cly Cly Clu Cly Cly Cly Amu Ber SBr Trp
239 To 1 CCL CYC TIC TCT TCC CCL CCT T TIC CM CM AC CAT ATC CM CMG CACMGCCC CTC CCL CMCCAG CCC AA CMC MA CM CC CC C CC CCCCO T CCC ALC ACC TCC TIC
Pro Va1 Pbe Sar gar Pro Pro Bar Tyr Pb. CGI CGI Tbr Rio I1 CIa Cl. Amp Pro Ale Lou Pro Thr Arg Clu Cly Lys Clu Arg Asp Cly Gly Clu Cly Cly Gly As SBr Bar Trp
239 To 2 CCL CTC TIC TCI?TC CCL CCC TCT TAT TIC TM CM ACC CAT AT CM CM CM CCC CA CTC CCL MC GA CGA CCC AL CA A CAC CC? CL CAL CCC CC? CCC ALC 6CC TCC
Pro Va1 Pbs Br Bar Pro Pro Bar Tyr nb - CIs Tbr Us Ile CIs CIs Asp Pro Ala Lea Pro Thr Arg Clu Cly Lys Clu Art Lsp Cly Cly GCi Cly Cly Cly Aso Bor SBr Trp
239 T0 3 CCL CTC TTC TCT TCC CC CCC TCT TAT TIC TM CMG MCC CAT ATC CAL CMG CMC CCC CCL CTC CCL MC MA CM CCC AM CM A C CC? CC CA CCC CC CCC MC MC TCC
TIC
Pro Va1 Pbs Bar Bar Pro Pro Bar Tyr Pbe - CGI Tbr Me Ile CIs CIs Asp Pro Al& Lao Pro Tbr Arg Clu Cly Lys Clu Arg Asp Cly Cly Clu Cly Cly Cly Ano SBr Ser Trp
239 T? 4 CCA CTC TIC T TI CCA CCC TCT TAT TTC TMG CM ACC CLT ATC CM CM C CCC COC Cl? CCL ACC MA GC CCC AAA CM MGA GAC C? CC CA CCC GCC CCC AAC 6CC TCC TIC
Pro V.1 Pbs Br Bar Pro Pro Btr Tyr Pbs - CGI Tbr UBl Ile CloCIs Asp Pro Ala Lsa Pro Tbr Arg Clu Cly Lys Clu Arg Asp Cly Cly Clu Cly Cly Cly Lso Bar SBr Trp
239 To 5 CCL CTI TIC TIT TCC CC CCC TCT TAT TIC TM CM ACC CAT ATC CM CM CC CCC OCL CM CCL 6CC AG CM CCC MA CM MGA C GCC? CC CM CC CCT CCC AC ACC TCC TIC
Pro V.1 Ptb Bar Bar Pro Pro Bar Tyr Pbs - Cia Thr Us Ile CGI CGI LAp Pro Al Lea Pro Tbr Arg Clu Cly Lye CGl Arg Asp Cly Cly Clu Cly Cly Cly Ao Ser Ser Trp
239 To 6 CCT CSCmT TCT TCC CCL CCC NTI TAT TIC CM CM ACC CAT ATC CAL TMG CMC CCL Cm CCL 6CC MA CM CCC ALL CM A OCMCCCL CM CAC CCT CC AC AGC TICC TCG
°Pro Va1 Pbs Bar Br Pro Pro Bar Tyr Pb. CIa CIs Tbr Et Ile CGI - LAp Pro Ala Los Pro ?hr Arg Clu Cly Lye Clu Arg LAp Cly Cly Clu Cly Ciy Cly Ao Ser Ser Trp
FIG. 4. Nucleotide and predicted amino acid sequences of the TMP region of SIVmac239 derivatives from HUT-78 cells. The sequence of
SIVmac239 is that of the parental clone (Fig. 1B). The sequences of SIVmac239 To1 through T06 represent clones prepared from Hirt
supernatant DNA of cloned SIVmac239-infected HUT-78 cells. Translational termination codons are indicated by dashed lines. No in-frame
stop codon is found in the SIVmac239 infectious clone, while five of six clones from SIVmac239-infected HUT-78 cells contain premature stop
codons.
(Fig. 5). In these macaque lymphocytes growing in interleu-
kin 2, replication of SIV with a 41-kDa TMP predominated.
Infection of macaque lymphocytes with SIVmac239/41K
yielded a virus with a 41-kDa TMP that persisted upon serial
passage (Fig. SA), while SIVmac239/28K eventually yielded a
virus with significant levels of a 41-kDa TMP (Fig. 5B).
These results suggested that truncated forms of the TMP of
SIVmac239 might result from selective growth in human
cells.
To further investigate this possibility, cloned SIVmac239
DNA was transfected directly into primary macaque and
human PBL cultures. In transfected macaque lymphocytes,
SIVmac239 replicated very well and maintained a 41-kDa
TMP over 80 days of serial passage (Fig. 6A). When
SIVmac239 cloned DNA was transfected into human PBL,
significant replication was delayed until after three passages.
After this time, virus replication increased dramatically,
coincident with the appearance of a virus with a 28-kDa TMP
which eventually predominated in the cultures (Fig. 6B).
Thus, virus with 28-kDa TMP is selected in normal human
PBL cultures similar to that seen with the human CD4+
tumor cell lines.
A rhesus monkey was previously infected with cloned
SIVmac239 (27). Since the virus used for infection was
harvested from SIVmac239-transfected HUT-78 cells, it con-
tained mainly a 28-kDa TMP (Fig. 7A). We recovered SIV
from CD4+-enriched lymphocytes of this rhesus monkey 58
weeks postinfection (reverse transcriptase activity was
81,000 cpm/ml at the time of harvest). Analysis of the virus
recovered from the persistently infected macaque showed
only a 41-kDa TMP (Fig. 7B).
DISCUSSION
In this report, we have shown that truncated forms of
TMP of SIVmac are strongly selected by growth in human
cell types. Truncated forms arise by cell culture selection of
point mutants with premature in-frame stop codons in env.
Replication of SIVmac in normal macaque lymphocytes pre-
ferred a full-length 41-kDa TMP. Expression of the cytoplas-
mic domain ofthe TMP ofSIVmac (i.e., the env region past the
premature stop codon) in vivo has been reported (10). These
results suggest that the natural form of the TMP of SIVmac is
the full-length 41-kDa protein, just as in HIV-1, and that
truncated forms of SIV appear to result from mutation and
selection during propagation in human cell lines.
In addition to SIVmac, SIV isolates from African green
monkeys, sooty mangabeys, and mandrills have exhibited
truncation of the TMP (12, 24, 26, 31). For these studies, SIV
was grown in human CD4+ T-cell lines. Several SIV isolates
from African green monkeys showed heterogeneity in the
sizes of their TMPs (20). After 3 months of culture of
SIVagm385 in MOLT-4/C18 cells (9), only a 41-kDa TMP was
detected in SIVagm385 preparations, but by 11 months a
truncated 34-kDa form predominated (T. Kodama and R.
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FIG. 5. Kinetics of viral replication and viral proteins of
SIVmac239/41K and SIVmac239/28K in macaque PBL. SIVmac239/
41K (27 days posttransfection) and SIVmac239/28K (82 days post-
transfection) were harvested from culture supernatants of HUT-78
cells that contained predominantly 41- and 28-kDa TMPs, respec-
tively (Fig. 3, experiment 1). The supernatant from each culture
used for inoculation of fresh cultures is indicated by open circles.
RTase, Reverse transcriptase.
TRANSMEMBRANE PROTEIN OF SIVmac 4713
S~~~~~....~~ 0 * i
: . ._-
B' SiVmoc239 Numcn PB8_
77~~~~_
.., w w~~~~~~~~~~~~~~~~~~~~~~.
..~~~ ~ ~ ~~~~~4
: ~ ~~~~~
.t, A
FIG. 6. Transfection of SIVmac239 into macaque (A) and human
(B) PBL. Viral replication was relatively delayed in human cells
compared with that of macaque cells until passage 3. The macaque
PBL continued to yield virus with 41-kDa TMP; however, the
human PBL selectively replicated a virus with a 28-kDa TMP. Open
symbols, culture supernatants used for passage; RTase, reverse
transcriptase.
Desrosiers, unpublished data). The selective pressure for
shorter versions of SIV TMP in human cells may vary with
the particular isolate, the species of origin, and the particular
human cells used for growth of the virus. In all likelihood,
however, use of human cells has contributed to the appear-
ance of shorter versions of the TMP with these different
viruses. Since adaptation of SIVmac to growth in human cell
types has been shown to select variants which are antigeni-
cally, genetically, and biologically distinguishable from the
original SIVmac, the use of human cell lines for isolation and
propagation of SIV should be avoided for many applications.
The premature stop codons are located in the cytoplasmic
region of the TMP, just after the membrane-spanning do-
main. Human and macaque cells apparently differ in their
requirements for cytoplasmic domain sequences to support
SIVmac replication. The cytoplasmic domain sequences are
likely to interact with cellular molecules in the process of
virus entry and in the assembly-and-budding process.
In addition to the TMP region, changes in the long
terminal repeat or other regions are likely to contribute to
selective growth of SIVmac in human cells. This may be
especially true for the HUT-78-adapted SIVmacl42 infec-
tious clone, which is not able to replicate significantly in
macaque lymphocytes or to infect macaque monkeys (25).
FIG. 7. Selection of SIVmac239 with a 41-kDa TMP in vivo. Viral
proteins present in derivatives of cloned SIVmac239 which were
harvested from a culture supernatant of HUT-78 cells for inocula-
tion into a macaque (A) and those of viruses recovered from a
T4-enriched PBL culture from a persistently infected macaque
monkey 58 weeks after inoculation (B) are shown.
The determinants of this inability to replicate in macaque
lymphocytes are likely to reside in regions other than that of
the TMP stop codon.
The location of the stop signal in env of SIVmac142 differed
from its location in SIVmac251 by only one codon. The
calculated molecular weights of the unglycosylated forms of
their TMPs are 23.8 kDa (SIVmac142) and 23.9 kDa
(SIVmac251), and each has three potential sites for N-linked
glycosylation. Unexpectedly, the TMP of the SIVmac251
virus was 2 kDa larger than that of SIVmac142 (30 versus 28
kDa) by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. The individual amino acid composition of the TMP
could possibly influence the rate at which it proceeds
through the Golgi or the nature or extent of glycosylation.
One possible origin of the HIVs is from monkeys via
cross-species transmission. If interspecies transmission of
SIV to humans did occur, we would expect adaptive muta-
tion to select variants better suited to replication and spread
in the human population.
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